Ajanta Pharma promoter Ravi Agrawal releases pledge on 1.6 lakh shares

Pledge ReleasedOwnership Changes View source PDF

AJANTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.4%1-day move

₹3423.00

prior close

₹3340.40

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1-0.0+0.2+0.2-2.4-2.5-1.4-3.2-4.1-1.7+0.8———

Up moveDown movePending

AI summary

Ravi Agrawal, trustee of Ravi Agrawal Trust and promoter of Ajanta Pharma, released a pledge on 1,60,000 equity shares (0.13 percent of total share capital) on June 30, 2026. The reason stated is excess pledge. Post-release, his pledged shares stand at 15.37 lakh (1.23 percent). The pledge was with Infina Finance for business financing.

Likely market impact

Release of excess pledge is a mildly positive signal, suggesting the promoter is reducing encumbrance and freeing up collateral on holdings.